The WWP1-JARID1B axis sustains acute myeloid leukemia chemoresistance.

Saved in:
Bibliographic Details
Title: The WWP1-JARID1B axis sustains acute myeloid leukemia chemoresistance.
Authors: Fierro C; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Giovannini S; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Moriconi V; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Fiorilli C; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Panatta E; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Frezza V; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Corigliano F; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Pecorari R; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy.; Biochemistry Laboratory, Istituto Dermopatico Immacolata, Rome 00100, Italy., Li Y; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy.; The First Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou 215000, China., Zhou J; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy.; Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu 215000, China., Delvecchio VS; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Smirnov A; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy.; Biochemistry Laboratory, Istituto Dermopatico Immacolata, Rome 00100, Italy., Manteiga JMG; Center for Omics Sciences, Istituti di Ricovero e Cura a Carattere Scientifico, San Raffaele Scientific Institute, Milan 20132, Italy., Brendolan A; Lymphoid stromal cell biology Unit, Division of Experimental Oncology, Istituti di Ricovero e Cura a Carattere Scientifico, San Raffaele Scientific Institute, Milan 20132, Italy., Zhang J; Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu 215000, China., Shi Y; The First Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou 215000, China., Amelio I; Systems Toxicology, Department of Biology, University of Konstanz, Konstanz 78464, Germany., Candi E; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy.; Biochemistry Laboratory, Istituto Dermopatico Immacolata, Rome 00100, Italy., Melino G; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy., Bernassola F; Department of Experimental Medicine, Tor Vergata Oncoscience Research, University of Rome Tor Vergata, Rome 00133, Italy.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2025 Jul 15; Vol. 122 (28), pp. e2421159122. Date of Electronic Publication: 2025 Jul 08.
Publication Type: Journal Article
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.2421159122